| pubmed-article:14627850 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0039416 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0137914 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0021107 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0178587 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0769169 | lld:lifeskim |
| pubmed-article:14627850 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:14627850 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:14627850 | pubmed:dateCreated | 2003-11-20 | lld:pubmed |
| pubmed-article:14627850 | pubmed:abstractText | Many materials and types of implant have been used to achieve a cosmetic effect and prosthesis motility in the anophthalmic socket. Hydroxyapatite remains the implant material of choice for producing the most natural prosthesis motility while porous polyethylene shows promising characteristics as another useful material. The aim of this study was to compare the fibrovascular ingrowth rates of orbital implants between coralline hydroxyapatite and high density porous polyethylene (Medpore). The fibrovascularization rate is determined by bone imaging using 99mTc methylene diphosphonate (99mTc-MDP) 6 months after implantation. Our study included 29 patients with coralline, and nine patients with Medpore implants. Our results showed that groups with coralline implants appearing to achieve complete fibrovascularization at a much more rapid rate than those with Medpore. The differences in rate were statistically significant. | lld:pubmed |
| pubmed-article:14627850 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14627850 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14627850 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14627850 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:14627850 | pubmed:issn | 0143-3636 | lld:pubmed |
| pubmed-article:14627850 | pubmed:author | pubmed-author:LawW TWT | lld:pubmed |
| pubmed-article:14627850 | pubmed:author | pubmed-author:RAEM VMV | lld:pubmed |
| pubmed-article:14627850 | pubmed:author | pubmed-author:NorI MIM | lld:pubmed |
| pubmed-article:14627850 | pubmed:author | pubmed-author:LiaoS-LSL | lld:pubmed |
| pubmed-article:14627850 | pubmed:author | pubmed-author:TzenK-YKY | lld:pubmed |
| pubmed-article:14627850 | pubmed:author | pubmed-author:WuY-WYW | lld:pubmed |
| pubmed-article:14627850 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14627850 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:14627850 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14627850 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14627850 | pubmed:pagination | 1237-41 | lld:pubmed |
| pubmed-article:14627850 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:meshHeading | pubmed-meshheading:14627850... | lld:pubmed |
| pubmed-article:14627850 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14627850 | pubmed:articleTitle | Different fibrovascularization rate between coralline hydroxyapatite and high density porous polyethylene (Medpore) measured by 99mTc-MDP bone scintigraphy 6 months after intraorbital implantation. | lld:pubmed |
| pubmed-article:14627850 | pubmed:affiliation | Department of Nuclear Medicine, National Taiwan University Hospital, Taipei. | lld:pubmed |
| pubmed-article:14627850 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14627850 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14627850 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:14627850 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
